MarketScreener Strategies Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 00:00:06 21/07/2026 +04			5-day change	1st Jan Change
474.88 ^USD	-2.22%		+1.06%	+7.05%

05:03pm	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating	MT
07-13	American Academy of Orthopaedic Surgeons Launches New Pain Management Resource Center in Partnership with Curonix LLC Pacira Biosciences, Inc., Vertex Pharmaceuticals, and Viatris	CI

	Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease	December 11, 2023 at 02:47 pm
	Vertex Pharmaceuticals Incorporated : Confirms growth trajectory	May 04, 2023 at 05:35 pm
	Vertex Pharmaceuticals : A very promising pipeline	January 11, 2023 at 02:20 pm